載入...
Combined inhibition of MEK and nuclear ERK translocation has synergistic antitumor activity in melanoma cells
Genetic alterations in BRAF, NRAS and NF1 that activate the ERK cascade, account for over 80% of metastatic melanomas. However, ERK cascade inhibitors have been proven beneficial almost exclusively for BRAF mutant melanomas. One of the hallmarks of the ERK cascade is the nuclear translocation of ERK...
Na minha lista:
| 發表在: | Sci Rep |
|---|---|
| Main Authors: | , , , , , , , |
| 格式: | Artigo |
| 語言: | Inglês |
| 出版: |
Nature Publishing Group UK
2017
|
| 主題: | |
| 在線閱讀: | https://ncbi.nlm.nih.gov/pmc/articles/PMC5704016/ https://ncbi.nlm.nih.gov/pubmed/29180761 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1038/s41598-017-16558-0 |
| 標簽: |
添加標簽
沒有標簽, 成為第一個標記此記錄!
|